Justin Heinonen and Jeremy Wilson, 2011
The creation of a product counterfeiting database highlights variation in known incidents of counterfeit pharmaceuticals across several important dimensions. By understanding how these incidents differ, researchers can provide empirical insights into the problem, develop evidence-based anti-counterfeit strategy and promote awareness to consumers, government and industry. This complex form of product counterfeiting involves offending specialists and generalists, has links to terrorist groups and puts the public’s health and safety at risk.
This article was published in Global Edge Business Review. Subscription may be required to view article.
2011 Copyright Michigan State University Board of Trustees.
To read the full article, click here.